The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement

Mark D. Stegall, Kenneth Troy Somerville, Matthew J. Everly, Roslyn B. Mannon, A. Osama Gaber, M. Roy First, Neetu Agashivala, Vanessa Perez, Kenneth A. Newell, Randall E. Morris, Debra Sudan, Klaus Romero, Sonya Eremenco, Maria Mattera, Nicole Spear, Amy C. Porter, Inish O'Doherty

Research output: Contribution to journalArticle

8 Scopus citations

Fingerprint Dive into the research topics of 'The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement'. Together they form a unique fingerprint.

Medicine & Life Sciences